EXAS logo

Exact Sciences Corporation (EXAS) Cash from financing

annual CFF:

$231.87M+$72.11M(+45.13%)
December 31, 2024

Summary

  • As of today (August 24, 2025), EXAS annual cash flow from financing activities is $231.87 million, with the most recent change of +$72.11 million (+45.13%) on December 31, 2024.
  • During the last 3 years, EXAS annual CFF has risen by +$223.40 million (+2636.95%).
  • EXAS annual CFF is now -87.66% below its all-time high of $1.88 billion, reached on December 31, 2020.

Performance

EXAS Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXAScash flow metrics

quarterly CFF:

-$4.51M+$251.66M(+98.24%)
June 30, 2025

Summary

  • As of today (August 24, 2025), EXAS quarterly cash flow from financing activities is -$4.51 million, with the most recent change of +$251.66 million (+98.24%) on June 30, 2025.
  • Over the past year, EXAS quarterly CFF has dropped by -$229.12 million (-102.01%).
  • EXAS quarterly CFF is now -100.46% below its all-time high of $979.48 million, reached on March 31, 2020.

Performance

EXAS quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXAScash flow metrics

TTM CFF:

-$250.41M-$229.12M(-1075.92%)
June 30, 2025

Summary

  • As of today (August 24, 2025), EXAS TTM cash flow from financing activities is -$250.41 million, with the most recent change of -$229.12 million (-1075.92%) on June 30, 2025.
  • Over the past year, EXAS TTM CFF has dropped by -$482.14 million (-208.06%).
  • EXAS TTM CFF is now -113.32% below its all-time high of $1.88 billion, reached on December 31, 2020.

Performance

EXAS TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXAScash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

EXAS Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+45.1%-102.0%-208.1%
3 y3 years+2636.9%-107.1%-563.5%
5 y5 years-8.4%-128.0%-125.0%

EXAS Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+2636.9%-102.0%+98.2%-208.0%at low
5 y5-year-87.7%+2636.9%-100.5%+98.2%-113.3%at low
alltimeall time-87.7%>+9999.0%-100.5%+98.2%-113.3%at low

EXAS Cash from financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$4.51M(-98.2%)
-$250.41M(+1075.9%)
Mar 2025
-
-$256.17M(-2540.0%)
-$21.30M(-109.2%)
Dec 2024
$231.87M(+45.1%)
$10.50M(-4745.6%)
$231.87M(+0.2%)
Sep 2024
-
-$226.00K(-100.1%)
$231.41M(-0.1%)
Jun 2024
-
$224.60M(-7581.8%)
$231.73M(+900.2%)
Mar 2024
-
-$3.00M(-129.9%)
$23.17M(-85.5%)
Dec 2023
$159.77M(+108.9%)
$10.04M(>+9900.0%)
$159.77M(-0.0%)
Sep 2023
-
$92.00K(-99.4%)
$159.83M(-0.1%)
Jun 2023
-
$16.04M(-88.0%)
$159.97M(-22.8%)
Mar 2023
-
$133.60M(+1222.3%)
$207.35M(+171.1%)
Dec 2022
$76.48M(+802.8%)
$10.10M(+4199.1%)
$76.48M(+41.2%)
Sep 2022
-
$235.00K(-99.6%)
$54.19M(+0.3%)
Jun 2022
-
$63.41M(+2218.5%)
$54.03M(+1263.8%)
Mar 2022
-
$2.73M(-122.4%)
$3.96M(-53.2%)
Dec 2021
$8.47M(-99.5%)
-$12.20M(<-9900.0%)
$8.47M(-99.1%)
Sep 2021
-
$81.00K(-99.4%)
$900.53M(-0.5%)
Jun 2021
-
$13.34M(+84.2%)
$904.60M(-0.3%)
Mar 2021
-
$7.25M(-99.2%)
$907.39M(-51.7%)
Dec 2020
$1.88B(+642.4%)
$879.86M(>+9900.0%)
$1.88B(+86.8%)
Sep 2020
-
$4.16M(-74.2%)
$1.01B(+0.3%)
Jun 2020
-
$16.12M(-98.4%)
$1.00B(+1.1%)
Mar 2020
-
$979.48M(>+9900.0%)
$992.53M(+292.0%)
Dec 2019
$253.18M(-72.9%)
$6.62M(+575.9%)
$253.18M(-1.1%)
Sep 2019
-
$980.00K(-82.0%)
$255.91M(-6.6%)
Jun 2019
-
$5.45M(-97.7%)
$274.00M(-45.4%)
Mar 2019
-
$240.13M(+2467.1%)
$501.83M(-46.3%)
Dec 2018
$934.14M(+258.0%)
$9.35M(-51.0%)
$934.14M(+0.7%)
Sep 2018
-
$19.07M(-91.8%)
$927.51M(+1.8%)
Jun 2018
-
$233.28M(-65.3%)
$910.89M(-2.4%)
Mar 2018
-
$672.44M(>+9900.0%)
$933.39M(+257.7%)
Dec 2017
$260.96M(+74.5%)
$2.72M(+10.5%)
$260.96M(-0.2%)
Sep 2017
-
$2.46M(-99.0%)
$261.60M(-35.2%)
Jun 2017
-
$255.78M(>+9900.0%)
$403.85M(+170.4%)
Mar 2017
-
$3000.00(-99.9%)
$149.34M(-0.2%)
Dec 2016
$149.59M(-17.7%)
$3.37M(-97.7%)
$149.59M(+0.6%)
Sep 2016
-
$144.71M(>+9900.0%)
$148.73M(-16.5%)
Jun 2016
-
$1.27M(+413.0%)
$178.19M(-1.9%)
Mar 2016
-
$247.00K(-90.2%)
$181.72M(-0.0%)
Dec 2015
$181.76M(-25.5%)
$2.51M(-98.6%)
$181.76M(-36.2%)
Sep 2015
-
$174.17M(+3532.2%)
$285.12M(+156.7%)
Jun 2015
-
$4.79M(+1525.4%)
$111.09M(-54.5%)
Mar 2015
-
$295.00K(-99.7%)
$244.32M(+0.1%)
Dec 2014
$244.03M(+228.4%)
$105.86M(>+9900.0%)
$244.03M(+76.6%)
Sep 2014
-
$136.00K(-99.9%)
$138.21M(-0.4%)
Jun 2014
-
$138.03M(>+9900.0%)
$138.71M(+86.7%)
Mar 2014
-
$2000.00(-95.5%)
$74.30M(-0.0%)
Dec 2013
$74.30M(+23.8%)
$44.00K(-93.1%)
$74.30M(-0.2%)
Sep 2013
-
$636.00K(-99.1%)
$74.45M(-43.5%)
Jun 2013
-
$73.62M(>+9900.0%)
$131.80M(+125.7%)
Mar 2013
-
$8000.00(-95.8%)
$58.40M(-2.7%)
Dec 2012
$60.04M
$191.00K(-99.7%)
$60.04M(-31.1%)
DateAnnualQuarterlyTTM
Sep 2012
-
$57.98M(>+9900.0%)
$87.19M(+195.2%)
Jun 2012
-
$222.00K(-86.5%)
$29.54M(+0.0%)
Mar 2012
-
$1.64M(-94.0%)
$29.53M(+5.8%)
Dec 2011
$27.90M(-67.2%)
$27.34M(+8161.0%)
$27.90M(-57.4%)
Sep 2011
-
$331.00K(+56.9%)
$65.46M(-1.7%)
Jun 2011
-
$211.00K(+1407.1%)
$66.56M(-20.8%)
Mar 2011
-
$14.00K(-100.0%)
$84.09M(-1.3%)
Dec 2010
$85.19M(+162.2%)
$64.90M(+4426.0%)
$85.19M(+300.1%)
Sep 2010
-
$1.43M(-91.9%)
$21.29M(+3.0%)
Jun 2010
-
$17.74M(+1499.9%)
$20.66M(+88.0%)
Mar 2010
-
$1.11M(+10.3%)
$10.99M(-66.2%)
Dec 2009
$32.49M(>+9900.0%)
$1.00M(+25.0%)
$32.49M(+3.2%)
Sep 2009
-
$804.00K(-90.0%)
$31.49M(+2.3%)
Jun 2009
-
$8.07M(-64.3%)
$30.79M(+35.5%)
Mar 2009
-
$22.61M(>+9900.0%)
$22.71M(>+9900.0%)
Dec 2008
$107.00K(-72.3%)
$1000.00(-99.0%)
$107.00K(-70.3%)
Sep 2008
-
$100.00K(>+9900.0%)
$360.00K(-4.5%)
Jun 2008
-
$0.00(-100.0%)
$377.00K(0.0%)
Mar 2008
-
$6000.00(-97.6%)
$377.00K(-2.3%)
Dec 2007
$386.00K(-18.4%)
$254.00K(+117.1%)
$386.00K(-20.6%)
Sep 2007
-
$117.00K(>+9900.0%)
$486.00K(+16.5%)
Jun 2007
-
$0.00(-100.0%)
$417.00K(-4.1%)
Mar 2007
-
$15.00K(-95.8%)
$435.00K(-8.0%)
Dec 2006
$473.00K(+245.3%)
$354.00K(+637.5%)
$473.00K(+300.8%)
Sep 2006
-
$48.00K(+166.7%)
$118.00K(-12.6%)
Jun 2006
-
$18.00K(-66.0%)
$135.00K(+11.6%)
Mar 2006
-
$53.00K(-5400.0%)
$121.00K(-11.7%)
Dec 2005
$137.00K(-99.7%)
-$1000.00(-101.5%)
$137.00K(-3.5%)
Sep 2005
-
$65.00K(+1525.0%)
$142.00K(-22.0%)
Jun 2005
-
$4000.00(-94.2%)
$182.00K(-59.0%)
Mar 2005
-
$69.00K(+1625.0%)
$444.00K(-99.0%)
Dec 2004
$43.94M(+3691.3%)
$4000.00(-96.2%)
$43.94M(-0.0%)
Sep 2004
-
$105.00K(-60.5%)
$43.94M(-1.7%)
Jun 2004
-
$266.00K(-99.4%)
$44.69M(+0.3%)
Mar 2004
-
$43.57M(>+9900.0%)
$44.54M(+3743.3%)
Dec 2003
$1.16M(+88.5%)
$7000.00(-99.2%)
$1.16M(-11.4%)
Sep 2003
-
$847.00K(+583.1%)
$1.31M(+100.3%)
Jun 2003
-
$124.00K(-31.5%)
$653.00K(+19.9%)
Mar 2003
-
$181.00K(+16.0%)
$544.50K(-11.5%)
Dec 2002
$615.00K(-98.8%)
$156.00K(-18.8%)
$615.00K(+19.0%)
Sep 2002
-
$192.00K(+1138.7%)
$517.00K(+11.2%)
Jun 2002
-
$15.50K(-93.8%)
$465.00K(+54.9%)
Mar 2002
-
$251.50K(+333.6%)
$300.10K(-99.4%)
Dec 2001
$50.78M(+58.7%)
$58.00K(-58.6%)
$50.78M(+0.1%)
Sep 2001
-
$140.00K(-193.7%)
$50.72M(+0.3%)
Jun 2001
-
-$149.40K(-100.3%)
$50.58M(-0.3%)
Mar 2001
-
$50.73M(>+9900.0%)
$50.73M(>+9900.0%)
Dec 2000
$31.99M(>+9900.0%)
-
-
Mar 2000
-
$1600.00
$1600.00
Dec 1999
$56.70K(-99.5%)
-
-
Dec 1998
$10.56M(+6077.6%)
-
-
Dec 1997
$171.00K
-
-

FAQ

  • What is Exact Sciences Corporation annual cash flow from financing activities?
  • What is the all time high annual CFF for Exact Sciences Corporation?
  • What is Exact Sciences Corporation annual CFF year-on-year change?
  • What is Exact Sciences Corporation quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Exact Sciences Corporation?
  • What is Exact Sciences Corporation quarterly CFF year-on-year change?
  • What is Exact Sciences Corporation TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Exact Sciences Corporation?
  • What is Exact Sciences Corporation TTM CFF year-on-year change?

What is Exact Sciences Corporation annual cash flow from financing activities?

The current annual CFF of EXAS is $231.87M

What is the all time high annual CFF for Exact Sciences Corporation?

Exact Sciences Corporation all-time high annual cash flow from financing activities is $1.88B

What is Exact Sciences Corporation annual CFF year-on-year change?

Over the past year, EXAS annual cash flow from financing activities has changed by +$72.11M (+45.13%)

What is Exact Sciences Corporation quarterly cash flow from financing activities?

The current quarterly CFF of EXAS is -$4.51M

What is the all time high quarterly CFF for Exact Sciences Corporation?

Exact Sciences Corporation all-time high quarterly cash flow from financing activities is $979.48M

What is Exact Sciences Corporation quarterly CFF year-on-year change?

Over the past year, EXAS quarterly cash flow from financing activities has changed by -$229.12M (-102.01%)

What is Exact Sciences Corporation TTM cash flow from financing activities?

The current TTM CFF of EXAS is -$250.41M

What is the all time high TTM CFF for Exact Sciences Corporation?

Exact Sciences Corporation all-time high TTM cash flow from financing activities is $1.88B

What is Exact Sciences Corporation TTM CFF year-on-year change?

Over the past year, EXAS TTM cash flow from financing activities has changed by -$482.14M (-208.06%)
On this page